company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,287000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1146000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1433000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1433000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1437000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1437000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1437000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,297000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1734000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5400000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5400000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5459066.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q2,2013-04-01,2013-06-30,2014-08-14 17:22:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,339000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1167000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1506000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1506000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1489000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1489000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1489000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,563000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2052000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5500000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5500000.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5485221.0
Kite Pharma Inc,KITE,,0001510580,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 14:53:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1070000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2092000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3162000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3162000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,21000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3141000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3141000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3141000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,557000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3698000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5600000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5600000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5571499.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 16:14:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3716000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7424000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11140000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11140000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6266000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6218000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17358000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17358000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17358000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,532000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17890000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7900000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.27
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7900000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7890029.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.27
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3385000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5716000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9101000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9101000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,61000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,50000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9051000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9051000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9051000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9051000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37700000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37700000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38330026.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q3,2014-07-01,2014-09-30,2015-11-12 16:01:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5398000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7857000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13255000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13255000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,242000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,236000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13019000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13019000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13019000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13019000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22900000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22900000.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.26
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22822204.0
Kite Pharma Inc,KITE,,0001510580,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2881000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2881000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2881000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9171000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9260000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18431000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15550000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,466000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,462000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15088000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15088000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15088000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15088000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41900000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41900000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42465737.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:07:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4403000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4403000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4403000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9774000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16588000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26362000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21959000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,498000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,570000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1067000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20892000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20892000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20892000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20892000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43500000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43500000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43249349.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 15:48:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5087000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5087000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5087000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11135000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21727000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32862000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27775000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,451000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,342000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-49000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-158000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27933000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-491000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27442000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27442000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27442000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43600000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43817798.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q3,2015-07-01,2015-09-30,2015-11-12 16:01:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4887000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4887000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4887000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14759000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28794000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43553000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38666000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-430000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,503000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,926000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37740000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,491000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38231000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38231000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38231000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43600000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43600000.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43636652.0
Kite Pharma Inc,KITE,,0001510580,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5127000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5127000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5127000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16683000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34414000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51097000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45970000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,816000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,845000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45125000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1209000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43916000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43916000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43916000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48800000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48800000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48831797.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 09:12:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4795000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4795000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4795000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23713000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47356000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71069000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66274000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,925000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,920000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-65354000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1080000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64274000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64274000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64274000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49100000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.31
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49100000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.31
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49156705.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 08:02:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.31
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7341000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7341000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7341000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25032000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57262000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82294000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-74953000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,196000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,942000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-31000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,715000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-74238000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-292000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-73946000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-73946000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-73946000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49600000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.49
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49600000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.49
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49624622.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 08:56:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.49
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4907000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4907000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4907000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31995000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58902000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90897000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-85990000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-183000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,941000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-381000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,743000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-85247000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-313000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84934000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84934000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-84934000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48900000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.76
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48900000.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.76
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48940290.0
Kite Pharma Inc,KITE,,0001510580,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.76
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9836000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9836000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9836000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35842000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,65906000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101748000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-91912000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1028000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,428000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1452000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-90460000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-100000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90360000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90399000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-90399000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52000000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.74
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52000000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.74
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51839500.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 09:12:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.74
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10052000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10052000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10052000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41101000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,70870000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111971000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-101919000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1222000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2366000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1144000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-103063000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6759000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-109822000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-109822000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-109822000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56600000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.94
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56600000.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.94
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56662639.0
Kite Pharma Inc,KITE,,0001510580,2017.0,Q2,2017-04-01,2017-06-30,2017-08-08 08:02:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.94
